~aseline glucose (GI), insulin (Ins), glucagon (Glucag) , cortisol (Cor) and alanine (Ala) deteqinations were drawn between 0-1 hours in 16 LBW infants (BW 1040-1490 gms. GA 29-34 wks.) after which an I.V. electrolyte-glucose (6 mglkglmin.) infusion was beaun. Repeat evaluations were done at 24 and 48 hrs Mean Values fir the 16 LBW Infants are Given Below
I l'hedata were analyzed according to B.W., gestational age, 5 1 inute apgar score and appropriateness for gestational age. Sig ificant findings were: glucose wasTin the group <I200 gms. at hrs. (p-.05) and 48 hrs. (p-<.02).
Insulin values in the apgar -5 group were+ (p=<.05) at 24 hrs. coincident with a trend toard hyperglycemia. Alanine and glucagon levels were higher in 11 groups at 0-1 hrs. (p-<.01).
No significant correlation between glycemia, insulin or ortisol levels could be found. Hyperglycemia was present in he groups <1200 gms. The presence of initially elevated lucagon and alanine levels in the immediate perinatal period uggest that the LBW infant is capable of active gluconeogenesis I 1 Charles J.Glueck,Reginald C.Tsang. University of ollege of Medicine,Department of Pediatrics,Cincinnay of South Florida College of Medicine,All Children's g/day. The serum was milky in appearance and had a creamy layer nd clear infranate after refrigeration. No hepatosplenomegaly, anthomata or lipemia retinalis were present. Triglycerides (TG) ere 10,720 mg/dl;cholesterol 530 mg/dl. Lipoprotein electrophoesis (LPE) showed a chylomicron band. Maternal and paternal LPE howed a type IV pattern. Extrahepatic postheparin lipolytic acvated: 33.2 mg/dl (~ormal 5t2.3 ~?~~) ;~e r c e n t of ApoCII in y low density lipoproteins (VLDL) was l w : 3.8 (~ormal 9.955.8 L net lipoprotein lipase activator (LPL-A) was low: 54 units/ (~ormal: 145.6t47.5). After 15 days on skim milk T~:1080 mg/ ;cholesterol 300 mg/dl. ApoCII activates extrahepatic lipoproin lipase (LPL) which hydrolyses TG in VLDL. Deficiency of LPL esults in severe hypertriglyceridemia. A deficiency of extraheatic LPL in this infant was associated with markedly elevated lasma ApoCI1,while ApoCII and LPL-A relative to VLDL were dereased. Overproduction of ApoCII in type I HLP is possibly a ompensatory mechanism for the LPL deficiency.
Lester Baker, James L. Mills, Charles A. Stanley. Univ. of Pa., Department of Pediatrics, Children's Hospital of Phila., Phila.
Twn natients. ages 5-6/12 E 8-10/12. with bio~sy-proven nlu-
c o~e~6~~h o s~h a t a s e deficiency were rkst6died 2-3/i2.&-2-8/12-yrr a f t e r starting nocturnal intragastric glucose infusion. Marked improvement in linear growth (velocities 11.3 & 7.5 cm/yr) was noted. Bone demineralization in both subjects was corrected anc a pathological fracture healed in one. Hepatmegaly was reducec Mean pre-therapy levels obtained after the usual overnight I f a s t werg compared-with mean pre-breakfast concentrations ob-I
(served a f t e r 2+ yrs of nighttime glucose infusion: These observations confirm that nocturnal intragastric glucose infusion i s of significant benefit in the long term t r e a tment of GSD I . Avoidance of hypoglycemia improved but did not totally correct the abnormalities of lactate and triglycerides. W e speculate that the clinical improvement i s due to correction of the chronic acidosis. 92%N2 ventilation (Pa02 20-30 t o r r ) for 45-min. produced a r i s e in plasma IRG (mean change +100.5 pg/ml) and glucose(+223.7mg/dl but no change in insulin (IRI) (-.3 pu/ml). However, when Group I was a i r ventilated (Pa02 >70 torr) and given 45-min. glucose irfusions producing hyperglycemia of similar degree (+I96 mg/dl), plasma IRG was unchanged (-7.8 pg/ml) while IRI (+32.8 pu/ml) rose. The I RG and IRI responses with 45-min. of hypoxia were different from those during a comparable period of a i r (p<.03). Because 6 adrenergic receptor stimulation mediates glucagon release in stressed dogs, i t s contribution to the I RG r i s e in hypoxia was examined by giving Group I1 the 0 adrenergic blocker propranolol . Despite 0 blockade, 8%02: 92%N2 ventilation causec a rise in plasma IRG (+394 pg/ml) and glucose (+71 mg/dl), but IRI was unchanged (+ .8 uu/ml). With propranolol and a i r ventil ation there were no significant changes in plasma IRG(+14.7pg/ml glucose (+9 mg/dl) or IRI (+6.7p~ml/). These data suggest that a ) glucagon release i s caused by acute 02 deficiency, but b) without B adrenergic receptor mediation. Since hepatic glycogenolysis, the primary glucose source in hypoxia, i s stimulated by glucagon and retarded by insulin, we propose that increased glucagon and low insulin levels promote glucose mobilization anc hyperglycemia a t low 02 tensions.
Medicine, Departments of Pediatrics and Chemistry, Stanford, California.
We have developed a convenient spectrophotometric free fatty acid binding index (FFABI) for monitoring infants receiving intravenous lipid supplements, who may be at risk due to hyperbilirubinemia or the possible direct toxicity of FFAs. We use the conjugated tetraene fatty acid parinaric acid (9,11,13,15 octadecatetraenoic acid), which has a sharply resolved absorption spectrum. The position of the absorption peak shifts upon binding to albumin. By measuring parinaric acid absorbance at two wavelengths in the presence of a serum sample diluted into buffer, we quantitate binding by comparison with albumin/FFA standards. An equal aliquot of serum is added to the reference cuvette to eliminate interference due to bilirubin, hemolysis, or turbidity. The measurement requires 20 microliters of serum and knowledge of the serum albumin concentration. No complex instrumentation or extraction into organic solvents are required. The index is sensitive both to elevation in FFA levels and to reduction in the affinity of albumin for FFAs. Nine infants not receiving intravenous lipid had FFABI values ranging from 0.3 to 2.0 (mean 1.4). Four infants receiving intravenous lipid had FFABI values of 2.1, 2.6, 3.2, and 3.4, respectively. We believe that monitoring of FFA binding in serum will be an important part ~f the rational management of infants receiving intravenous lipid The appearance of rickets in a 6 year old girl receiving MTX for acute lymphatic leukemia prompted a study of the effects of this compound on calcium transport and bone mineralization in animal models. Five days after a single MTX dose (15 mg/~' IP) rats showed a 75% decrease in TCa as measured in everted duodenal sacs. A second dose reduced TCa to 8% of the control value it then increased gradually, reaching 78% 20 days after the second MTX dose.
Chicks were kept on a synthetic diet with just sufficient Ca and vitamin D (D) for normal growth in controls. After MTX (15 D R / M~ IP x 2). growth retardation (6.7 gmlday vs. 10 gmfday), kmpaired gait, and radiographic evidence of rickets were seen at 20 days. Dietary Ca and D were then increased; growth rate, gait .nd radiographs returned to normal in 8 days, though MTX was ~ontinued.
In the models described, MTX reduced TCa. Bone mineralization <as compromised when Ca and D intake were just adequate; in-:reased Ca and D permitted remineralization. These results suggest that MTX might cause bone disease in patients with low c >orderline Ca and D intake; the ample quantities of both in the isual North American diet would be protective.
